N. Tubridy

发表

Gait and balance impairment in early multiple sclerosis in the absence of clinical disability

B. Phillips, M. Galea, C. Martin, 2006, Multiple sclerosis.

Only Low Frequency Event-Related EEG Activity Is Compromised in Multiple Sclerosis: Insights from an Independent Component Clustering Analysis

Richard B. Reilly, Michael Hutchinson, Hugh Nolan, 2012, PloS one.

Impaired information processing speed and attention allocation in multiple sclerosis patients versus controls: A high-density EEG study

R. Whelan, N. Tubridy, H. Kiiski, 2010, Journal of the Neurological Sciences.

A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).

M. Hutchinson, N. Tubridy, K. O'Connell, 2015, Multiple sclerosis and related disorders.

Neuroradiological history: Sir Joseph Larmor and the basis of MRI physics

N. Tubridy, C. McKinstry, 2000, Neuroradiology.

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

Simon C. Potter, Joseph T. Glessner, M. Pirinen, 2011, Nature.

Short Bouts of Gait Data and Body-Worn Inertial Sensors Can Provide Reliable Measures of Spatiotemporal Gait Parameters from Bilateral Gait Data for Persons with Multiple Sclerosis

B. Caulfield, N. Tubridy, B. Greene, 2020, Biosensors.

Neurosarcoidosis: clinical presentations and changing treatment patterns in an Irish Caucasian population

N. Tubridy, S. O'Riordan, K. O'Connell, 2017, Irish Journal of Medical Science (1971 -).

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Margaret Burnett, Gavin Giovannoni, 2018, The Lancet.

Congenital myopathies and congenital muscular dystrophies

N. Tubridy, B. Eymard, B. Fontaine, 2001, Current opinion in neurology.

Using atypical symptoms and red flags to identify non-demyelinating disease

M. Hutchinson, N. Tubridy, C. Walsh, 2011, Journal of Neurology, Neurosurgery & Psychiatry.

Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial

T. Ziemssen, N. Tubridy, J. Frederiksen, 2014, Journal of Neurology.

Delayed P100-Like Latencies in Multiple Sclerosis: A Preliminary Investigation Using Visual Evoked Spread Spectrum Analysis

E. Lalor, R. Reilly, R. Whelan, 2016, PloS one.

IRAK1 Limits TLR3/4- and IFNAR-Driven IL-27 Production through a STAT1-Dependent Mechanism

D. Bruni, N. Tubridy, K. O'Connell, 2018, The Journal of Immunology.

Neuroglial responses to CNS injury: prospects for novel therapeutics

Bruce V Taylor, Helmut Butzkueven, Niall Tubridy, 2004, Expert review of neurotherapeutics.

Anti-nmda-receptor Antibody-mediated Cortical Blindness: a Case Report Learning Point for Clinicians

N. Tubridy, S. Connolly, M. Farrell, 2022 .

Should we call the neurologist? The value and cost of a growing neurology consultation service

N. Tubridy, N. Broderick, C. Farrell, 2016, Irish Journal of Medical Science (1971 -).

Machine Learning EEG to Predict Cognitive Functioning and Processing Speed Over a 2-Year Period in Multiple Sclerosis Patients and Controls

Michael Hutchinson, Hugh Nolan, Robert Whelan, 2018, Brain Topography.

Change in PASAT performance correlates with change in P3 ERP amplitude over a 12-month period in multiple sclerosis patients

R. Whelan, N. Tubridy, J. Bramham, 2011, Journal of the Neurological Sciences.

Vaccine hesitancy among people with multiple sclerosis

H. Kearney, N. Tubridy, C. McGuigan, 2021, Multiple Sclerosis and Related Disorders.

What difference does a neurologist make in a general hospital? Estimating the impact of neurology consultations on in-patient care

M. Hutchinson, N. Tubridy, K. Roberts, 2007, Irish journal of medical science.

Analysing the effect of multiple sclerosis on vitamin D related biochemical markers of bone remodelling

R. Segurado, N. Tubridy, R. Lonergan, 2017, The Journal of Steroid Biochemistry and Molecular Biology.

Moyamoya disease and moyamoya syndrome in Ireland: patient demographics, mode of presentation and outcomes of EC-IC bypass surgery

S. Cronin, N. Tubridy, C. McGuigan, 2020, Irish Journal of Medical Science (1971 -).

Incidence of multiple sclerosis in the Republic of Ireland: A prospective population-based study.

M. Hutchinson, N. Tubridy, K. O'Connell, 2017, Multiple sclerosis and related disorders.

Posterior reversible encephalopathy syndrome with Lilliputian hallucinations secondary to Takayasu's arteritis

N. Tubridy, J. Duignan, R. Killeen, 2020, Radiology case reports.

Word finding, prosody and social cognition in multiple sclerosis.

R. Reilly, H. Kearney, N. Tubridy, 2022, Journal of neuropsychology.

Headaches in a rheumatology clinic: when one pain leads to another

N. Tubridy, K. O'Connell, L. Williams, 2008, European journal of neurology.

CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis1

N. Tubridy, R. Lonergan, K. Kinsella, 2009, The Journal of Immunology.

IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells

N. Tubridy, R. Lonergan, K. Kinsella, 2011, Brain, Behavior, and Immunity.

Multiple Sclerosis Pathogenic Th 17 Cells and Are Impaired in Regulatory T Cells Suppress + Foxp 3 + CD 39

Kinsella, N. Tubridy, R. Lonergan, 2009 .

Infundibulohypophysitis in a man presenting with diabetes insipidus and cavernous sinus involvement

G. Plant, M. Thom, D. Saunders, 2001, Journal of neurology, neurosurgery, and psychiatry.

Late-onset progressive visual loss in a man with unusual MRI findings: MS, Harding’s, Leber’s or Leber’s Plus ?

N. Tubridy, N. Cawley, A. Molloy, 2010, Irish journal of medical science.

Multiple sclerosis, from referral to confirmed diagnosis: an audit of clinical practice

M. Hutchinson, N. Tubridy, S. Kelly, 2011, Multiple sclerosis.

Comparative efficacy of disease-modifying therapies for patients with relapsing remitting multiple sclerosis: Systematic review and network meta-analysis.

M. Barry, N. Tubridy, C. Walsh, 2016, Multiple sclerosis and related disorders.

Large scale calcium channel gene rearrangements in episodic ataxia and hemiplegic migraine: implications for diagnostic testing

D. Kullmann, S. Schorge, N. Tubridy, 2009, Journal of Medical Genetics.

Spontaneous intracranial hypotension: case reports and literature review

M. Hutchinson, N. Tubridy, D. O’Keeffe, 2012, Irish Journal of Medical Science.

Investigating the association of mood and fatigue with objective and subjective cognitive impairment in multiple sclerosis.

N. Tubridy, J. Bramham, R. Monaghan, 2022, Journal of neuropsychology.

A pilot study of the immunological effects of high-dose vitamin D in healthy volunteers

M. Hutchinson, N. Tubridy, C. Walsh, 2012, Multiple sclerosis.

Counting the cost of complementary and alternative therapies in an Irish neurological clinic

M. Hutchinson, N. Tubridy, A. Rogers, 2008, European journal of neurology.

Association between speech rate measures and cognitive function in people with relapsing and progressive multiple sclerosis

R. Reilly, N. Tubridy, C. Looze, 2022, Multiple sclerosis journal - experimental, translational and clinical.

Auditing the frequency and the clinical and economic impact of testing for Fabry disease in patients under the age of 70 with a stroke admitted to Saint Vincent’s University Hospital over a 6-month period

N. Tubridy, R. Lonergan, I. Noone, 2018, Irish Journal of Medical Science (1971 -).

Longitudinal stability of JCV antibody index in Natalizumab treated people with multiple sclerosis.

N. Tubridy, C. McGuigan, I. McGurgan, 2022, Multiple sclerosis and related disorders.

A case of progressive multifocal leukoencephalopathy in a patient with sarcoidosis.

F. Brett, N. Tubridy, M. Keane, 2012, QJM : monthly journal of the Association of Physicians.

Interpreting the clinical importance of the relationship between subjective fatigue and cognitive impairment in multiple sclerosis (MS): How BICAMS performance is affected by MS-related fatigue.

N. Tubridy, J. Bramham, R. Monaghan, 2022, Multiple sclerosis and related disorders.

Unsuccessful treatment with cidofovir and cytarabine in progressive multifocal leukoencephalopathy associated with dermatomyositis

N. Tubridy, F. Schon, C. Wells, 2000, Journal of the Royal Society of Medicine.

T cells in multiple sclerosis and experimental autoimmune encephalomyelitis

N. Tubridy, K. Mills, N. Tubridy, 2010, Clinical and experimental immunology.

Increased expression of Tbet in CD4+ T cells from clinically isolated syndrome patients at high risk of conversion to clinically definite MS

N. Tubridy, S. Kelly, K. O'Connell, 2016, SpringerPlus.

Does natalizumab therapy worsen neuromyelitis optica?

M. Hutchinson, N. Tubridy, S. Kelly, 2012, Neurology.

The effect of anti-α4 integrin antibody on brain lesion activity in MS

Jacqueline Palace, A. Chaudhuri, D. Miller, 1999, Neurology.

Encephalitis with mGluR5 antibodies

N. Tubridy, M. Rosenfeld, J. Antoine, 2018, Neurology.

The effect of section thickness on magnetic resonance lesion detection and quantification in multiple sclerosis

G. Barker, D. MacManus, G. Parker, 1998 .

Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians

T. Speed, T. Kilpatrick, H. Butzkueven, 2008, Genes and Immunity.

Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis

T. Speed, T. Kilpatrick, H. Butzkueven, 2004, Human Genetics.

Pediatric Parainfectious Encephalitis Associated With COVID-19

N. Tubridy, S. O'Riordan, C. McGuigan, 2021, Neurology.

Clinical Reasoning: An unusual case of papilledema after orthotopic liver transplantation

Michael K. Hutchinson, N. Tubridy, G. Gorman, 2009, Neurology.

Ophelia syndrome with metabotropic glutamate receptor 5 antibodies in CSF

N. Tubridy, J. Dalmau, G. Gullo, 2013, Neurology.

Intermittent claudication – atypical presentation, diagnosis and treatment

N. Tubridy, X. Dennett, I. Taylor, 2004, Journal of Clinical Neuroscience.

Visualisation of the medial longitudinal fasciculus using fibre tractography in multiple sclerosis patients with internuclear ophthalmoplegia

N. Tubridy, R. O’laoide, R. Lonergan, 2016, Irish Journal of Medical Science (1971 -).

Diagnostic Efficacy of Conventional MRI Pulse Sequences in the Detection of Lesions Causing Internuclear Ophthalmoplegia in Multiple Sclerosis Patients

P. C. Brennan, R. Lonergan, N. Tubridy, 2015, Clinical Neuroradiology.

Reactivation of BK polyomavirus in patients with multiple sclerosis receiving natalizumab therapy

M. Hutchinson, N. Tubridy, S. Coughlan, 2009, Journal of NeuroVirology.

HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis.

T. Kilpatrick, H. Butzkueven, N. Tubridy, 2009, Tissue antigens.

Cladribine followed by autologous stem‐cell transplantation in progressive multiple sclerosis

H. Butzkueven, N. Tubridy, J. Szer, 2004, Internal medicine journal.

Intercellular adhesion molecule-1: a protective haplotype against multiple sclerosis

E. Génin, M. Clanet, F. Clerget-Darpoux, 2003, Genes and Immunity.

Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype

M. Hutchinson, N. Tubridy, R. Lonergan, 2011, Journal of Neurology, Neurosurgery & Psychiatry.

National scientific medical meeting 1995 abstracts

G. R. Fitzgerald, W. K. Cullen, M. Rowan, 1995, Irish journal of medical science.

Pulmonary Oedema with Multiple Sclerosis

N. Tubridy, A. Sirker, R. Peatfield, 2002, Journal of the Royal Society of Medicine.

Neurological Symptoms 27 Years after Tiger Bite

N. Tubridy, F. Johnston, D. Wren, 1999, Journal of the Royal Society of Medicine.

Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20

Pablo Moscato, Rodney J. Scott, Brian L. Browning, 2009, Nature Genetics.

Lhermitte-Duclos and Cowden diseases: breast cancer as an unusual initial presentation of these overlapping conditions

E. McDermott, N. Tubridy, S. Walsh, 2011, BMJ Case Reports.

Unusual MRI abnormalities in anti-Yo positive "pure" paraneoplastic cerebellar degeneration

M. Hutchinson, N. Tubridy, J. McHugh, 2008, Journal of neurology.

Postpartum pituitary hypophysitis.

G. Plant, D. Saunders, N. Tubridy, 2001, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

Bilateral foot-drop and electroconvulsive therapy

M. Hutchinson, N. Tubridy, B. O'Shea, 1996, Irish Journal of Psychological Medicine.

Hippocampal involvement in identical twins with neurofibromatosis type 1

N. Tubridy, R. Ferner, F. Schon, 2001, Journal of neurology, neurosurgery, and psychiatry.

The Woman who Mistook the Past for the Present A 'variant' presentation of an old disease: a further differential for the 'pulvinar sign'.

M. Hutchinson, N. Tubridy, D. Murphy, 2006 .

The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group.

D. MacManus, A. Chaudhuri, D. Miller, 1999, Neurology.

Clinical Reasoning: A case of Wegener granulomatosis complicated by seizures and headaches

M. Hutchinson, N. Tubridy, G. Gorman, 2009, Neurology.

M. Hutchinson, N. Tubridy, C. Walsh, 2013, Trials.

Attitudes of US medical trainees towards neurology education: "Neurophobia" - a global issue

Louise D McCullough, L. McCullough, N. Tubridy, 2010, BMC medical education.

‘Neurophobia’– attitudes of medical students and doctors in Ireland to neurological teaching

N. Tubridy, C. Walsh, E. Flanagan, 2007, European journal of neurology.

The ‘hidden work’ of a hospital neurologist: 1000 consults later

M. Hutchinson, N. Tubridy, E. Chaila, 2010, European journal of neurology.

The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical)

H. Kearney, M. Hutchinson, N. Tubridy, 2007, Journal of Neurology, Neurosurgery & Psychiatry.

Generating hand dysaesthesiae: the “GHD phenomenon” – straight to the diagnosis

N. Tubridy, R. Lonergan, G. Gorman, 2009, BMJ Case Reports.

A web-based electronic neurology referral system: a solution for an overburdened healthcare system?

M. Hutchinson, N. Tubridy, C. McGuigan, 2012, Irish medical journal.

Parkinson’s disease: how is employment affected?

N. Tubridy, R. Murphy, H. Kevelighan, 2013, Irish Journal of Medical Science.

Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis

M Rovaris, F Barkhof, M Filippi, 1997, Neurology.

OAS1: A multiple sclerosis susceptibility gene that influences disease severity

M. Hutchinson, N. Tubridy, R. Lonergan, 2010, Neurology.

Secondary progressive multiple sclerosis: the relationship between short-term MRI activity and clinical features.

A. Thompson, F. Barkhof, W. Mcdonald, 1998, Brain : a journal of neurology.

Exploratory treatment trials in multiple sclerosis using MRI: sample size calculations for relapsing-remitting and secondary progressive subgroups using placebo controlled parallel groups

A. Thompson, F. Barkhof, N. Tubridy, 1998, Journal of neurology, neurosurgery, and psychiatry.

Discontinuing disease-modifying therapy in progressive multiple sclerosis: can we stop what we have started?

M. Hutchinson, N. Tubridy, R. Lonergan, 2009, Multiple sclerosis.

The effect of section thickness on MR lesion detection and quantification in multiple sclerosis.

G. Barker, D. MacManus, G. Parker, 1998, AJNR. American journal of neuroradiology.

Short-term effects of methylprednisolone on cerebral volume in multiple sclerosis relapses

T. Kilpatrick, H. Butzkueven, N. Tubridy, 2006, Journal of Clinical Neuroscience.

Impact of obstructive sleep apnoea on cognitive function in multiple sclerosis: A longitudinal study

M. Hutchinson, N. Tubridy, C. McGuigan, 2020, Journal of sleep research.

Assessment and Classification of Early-Stage Multiple Sclerosis With Inertial Sensors: Comparison Against Clinical Measures of Disease State

Barry R. Greene, Brian Caulfield, Christopher McGuigan, 2015, IEEE Journal of Biomedical and Health Informatics.

Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease

M. Hutchinson, A. Thompson, N. Tubridy, 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

Postural stability is a valid and meaningful disability metric in progressive MS with potential for use in neuroprotective therapy trials.

Mark S. Etzelmueller, R. Reilly, H. Kearney, 2021, Multiple sclerosis and related disorders.

Quantitative assessment of multiple sclerosis using inertial sensors and the TUG test

Michael Healy, Brian Caulfield, Barry R. Greene, 2014, 2014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

Perceived and objective cognitive impairment in newly diagnosed versus established multiple sclerosis: impact of disease duration

M. Hutchinson, N. Tubridy, C. McGuigan, 2020, Irish Journal of Medical Science (1971 -).

Premorbid cognitive functioning influences differences between self-reported cognitive difficulties and cognitive assessment in multiple sclerosis.

N. Tubridy, J. Bramham, F. O’Keeffe, 2023, Journal of neuropsychology.

Effects of vitamin D3 in clinically isolated syndrome and healthy control participants: A double-blind randomised controlled trial

M. Hutchinson, N. Tubridy, C. Walsh, 2017, Multiple sclerosis journal - experimental, translational and clinical.

Preliminary evidence for correlation between PASAT performance and P3a and P3b amplitudes in progressive multiple sclerosis

R. Whelan, M. Hutchinson, N. Tubridy, 2011, European journal of neurology.

Failure to attend out-patient clinics: is it in our DNA?

N. Tubridy, I. Callanan, K. Roberts, 2011, International journal of health care quality assurance.

Multiple sclerosis: interobserver agreement in reporting active lesions on serial brain MRI using conventional spin echo, fast spin echo, fast fluid-attenuated inversion recovery and post-contrast T1-weighted images

F. Barkhof, M. Rovaris, M. Filippi, 1999, Journal of Neurology.

New versus old: Implications of evolving diagnostic criteria for relapsing–remitting multiple sclerosis

M. Hutchinson, N. Tubridy, K. O'Connell, 2019, Multiple sclerosis.

Direct and Indirect Economic Consequences of Multiple Sclerosis in Ireland

M. Barry, N. Tubridy, C. Walsh, 2014, Applied Health Economics and Health Policy.

Expansion of the Spectrum of FLNA Mutations Associated with Melnick-Needles Syndrome

N. Tubridy, A. Fryer, T. Morgan, 2010, Molecular Syndromology.

Neurology of Fabry disease

N. Tubridy, L. Kiers, D. Velakoulis, 2007, Internal medicine journal.

A proposed modification to the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis

M. Hutchinson, N. Tubridy, K. Kinsella, 2013, Multiple sclerosis.

Illness perception and health‐related quality of life in multiple sclerosis

T. Kilpatrick, N. Tubridy, S. Adams, 2007, Acta neurologica Scandinavica.

The longitudinal relationship between the patient-reported Multiple Sclerosis Impact Scale and the clinician-assessed Multiple Sclerosis Functional Composite

M. Hutchinson, N. Tubridy, C. Walsh, 2008, Multiple sclerosis.

Optimisation of unenhanced MRI for detection of lesions in multiple sclerosis: a comparison of five pulse sequences with variable slice thickness

G. Barker, D. MacManus, I. Moseley, 1998, Neuroradiology.

Unmet needs of multiple sclerosis patients in the community.

M. Hutchinson, N. Tubridy, R. Lonergan, 2015, Multiple sclerosis and related disorders.

Three-dimensional fast fluid attenuated inversion recovery (3D fast FLAIR): a new MRI sequence which increases the detectable cerebral lesion load in multiple sclerosis.

G. Barker, D. MacManus, I. Moseley, 1998, The British journal of radiology.

Economic costs associated with an MS relapse.

M. Hutchinson, N. Tubridy, S. Kelly, 2014, Multiple sclerosis and related disorders.

Five-year follow up of the original Irish BICAMS validation cohort.

N. Tubridy, R. Monaghan, F. O’Keeffe, 2021, Multiple sclerosis and related disorders.

The sensitivity of thin-slice fast spin echo, fast FLAIR and gadolinium-enhanced T1-weighted MRI sequences in detecting new lesion activity in multiple sclerosis

I. Moseley, N. Tubridy, P. Molyneux, 1999, Journal of Neurology.

A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial

T. Ziemssen, N. Tubridy, J. Frederiksen, 2014, Journal of Neurology.

The Face-Symbol Test and the Symbol-Digit Test are not reliable surrogates for the Paced Auditory Serial Addition Test in multiple sclerosis

M. Hutchinson, N. Tubridy, K. O’Rourke, 2006, Multiple sclerosis.

Long term use of Desmopressin for urinary symptoms in multiple sderosis

N. Tubridy, F. Schon, R. Addison, 1999, Multiple sclerosis.

Reversible amnesia following opiate overdose: CHANTER syndrome.

N. Tubridy, R. O’Donohoe, Audrey Reynolds, 2023, Practical neurology.

Superior orbital fissure syndrome in herpes zoster ophthalmicus

N. Tubridy, R. Kirwan, A. Hogan, 2009, Irish journal of medical science.

"Popcorn" in the brain: A cause for confusion.

N. Tubridy, R. Killeen, S. Rafee, 2020, The American journal of medicine.

Relating health-related Quality of Life to disability progression in multiple sclerosis, using the 5-level EQ-5D

M. Barry, N. Tubridy, C. Walsh, 2013, Multiple sclerosis.

Neurological symptoms attributed to epidural analgesia in labour: an observational study of seven cases

N. Tubridy, J. Redmond, 1996, British journal of obstetrics and gynaecology.

Myasthenia gravis: a population-based epidemiological study.

N. Tubridy, C. McGuigan, S. Rutledge, 2016, Irish medical journal.

Symptom overlap in anxiety and multiple sclerosis

R. Reilly, R. Whelan, M. Hutchinson, 2013, Multiple sclerosis.

Headaches, neurologists and the emergency department.

N. Tubridy, Gaughran Cg, 2014, Irish medical journal.

IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells

N. Tubridy, R. Lonergan, K. Kinsella, 2011, Brain, Behavior, and Immunity.

A high-density ERP study reveals latency, amplitude, and topographical differences in multiple sclerosis patients versus controls

H. Nolan, R. Lonergan, R. Whelan, 2010, Clinical Neurophysiology.

Using atypical symptoms and red flags to identify non-demyelinating disease

M. Hutchinson, N. Tubridy, C. Walsh, 2011, Journal of Neurology, Neurosurgery & Psychiatry.

Relating health-related Quality of Life to disability progression in multiple sclerosis, using the 5-level EQ-5D

M. Barry, N. Tubridy, C. Walsh, 2013, Multiple sclerosis.

Quantitative assessment of multiple sclerosis using inertial sensors and the TUG test

B. Caulfield, N. Tubridy, Michael Healy, 2014, 2014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

An evaluation of optimal tutorial methodologies for neurology teaching at undergraduate level

H. Kearney, N. Tubridy, I. Callanan, 2020, Irish Journal of Medical Science (1971 -).

[Genetic factors in multiple sclerosis].

N. Tubridy, B. Fontaine, I. Cournu-Rebeix, 2001, Presse medicale.

Title: a High-density Erp Study Reveals Latency, Amplitude, and Topographical Reilly (ebiomed: Ehealthcare Based on Biomedical Signal Processing and Ict for Integrated Diagnosis and Treatment of Disease)

R. Whelan, M. Hutchinson, N. Tubridy, 2010 .